peptide database · 8 graded compounds · 6 measured in people
peptides for gut health: what the research shows
8 graded compounds were studied for gut, 6 of them in people. Each is graded A to F on published evidence; the ladder shows how far research got, from cell studies to approval.
- Liraglutidemeasured in people$10.20/mg
- Semaglutidemeasured in people$6.00/mg
- Tirzepatidemeasured in people$3.50/mg
- Cagrilintidemeasured in people$10.00/mg
- Retatrutidemeasured in people$6.25/mg
- Ipamorelinmeasured in people$5.00/mg
- BPC-157animal or cell studies$5.67/mg
- KPVanimal or cell studies$5.00/mg
3D anatomy: Human Reference Atlas reference organs from the NIH Visible Human Project (CC BY 4.0) and BodyParts3D, © The Database Center for Life Science (CC BY-SA 2.1 JP), fitted to each body and simplified by PeptideTech; the adapted BodyParts3D meshes are shared under the same licence. Lymph node clusters, the thyroid, joint capsules and the fat layer are drawn for orientation.
research market · not for human use
Evidence grades come from the published literature; no vendor can pay for a grade or a ranking. Some outbound links are affiliate links; they never affect grades, scores or order.
gut
evidence table
| compound | grade | highest rung | US status | body systems | from $/mg | studies |
|---|---|---|---|---|---|---|
| Liraglutide GLP-1 agonist | approved somewhere | FDA-approved | fat & metabolismgutheart | $10.20 | research profile | |
| Semaglutide GLP-1 agonist | approved somewhere | FDA-approved | fat & metabolismgutheartkidneysliver | $6.00 | research profile | |
| Tirzepatide GIP/GLP-1 dual agonist | approved somewhere | FDA-approved | fat & metabolismgutliverheartlungs & airway | $3.50 | research profile | |
| Cagrilintide long-acting amylin analogue | phase 3 trial | investigational | fat & metabolismgutbrain & mood | $10.00 | research profile | |
| Retatrutide GIP/GLP-1/glucagon triple agonist | phase 2 trial | investigational | fat & metabolismlivergut | $6.25 | research profile | |
| Ipamorelin ghrelin-receptor agonist | phase 2 trial | compounding restricted | hormone axisgut | $5.00 | research profile | |
| BPC-157 body protection compound 157 | small human studies | rulemaking pending | guttendons & jointsmuscleskin & hair | $5.67 | research profile | |
| KPV α-MSH fragment | animal studies | rulemaking pending | gutskin & hair | $5.00 | research profile |
short answers
